Bullish
Danaher Corp. is a global science and technology company providing diversified tools and services in life sciences, diagnostics, and environmental sol...
Bullish
Danaher (DHR) shares rose 2.8% after its newly acquired subsidiary, Masimo, secured FDA clearance for an AI-enabled feature to detect opioid-induced r...
Danaher Corp (DHR) stock surged 4.91% due to renewed investor optimism in the biotechnology and life sciences sectors, bolstered by the successful int...
Danaher's company, Masimo, recently received FDA clearance for an AI-enabled opioid-induced respiratory depression detection feature in its wearable p...
Danaher Corporation (DHR) announced it will webcast its second-quarter 2026 earnings conference call on Tuesday, July 21, 2026, at 8:00 a.m. ET. The c...
Danaher (NYSE:DHR) announced it will host its second quarter 2026 earnings conference call on July 21, 2026, starting at 8:00 a.m. ET. The company wil...
Bullish
Danaher Corporation (NYSE:DHR) is set to trade ex-dividend in three days, with a dividend payment of US$0.40 per share, totaling US$1.60 annually, yie...
Neutral
Storen Legacy Partners LLC purchased a new stake in Danaher Corporation (NYSE:DHR – Free Report) in the 4th quarter, according to the company in its m...
Bullish
Molecular medical technology company Cepheid, the largest private employer in Lodi, has opened a new 180,000-square-foot warehouse, expanding its oper...
Neutral
Crawford Investment Counsel Inc. purchased a new stake in Danaher Corporation (NYSE:DHR – Free Report) in the 4th quarter, HoldingsChannel.com reports...
Neutral
Oddo BHF Asset Management Sas boosted its stake in Danaher Corporation (NYSE:DHR – Free Report) by 92.9% during the 4th quarter, Holdings Channel.com ...
Bullish
Masimo CEO Katie Szyman is stepping down following Danaher Corporation's finalization of its $9.9 billion acquisition of Masimo. Masimo will now opera...
Neutral
Danaher Corporation's Q1 2026 performance, as noted by Madison Large Cap Fund, fell short of investor expectations despite a projected end-market reco...
Masimo's EVP and General Counsel, Charles Dadswell, reported the disposal of two blocks of restricted stock units (RSUs) totaling 22,147 units on June...
Masimo's Chief Marketing Officer, Tim Benner, disposed of various equity awards, including performance-based and time-based RSUs and non-qualified sto...
Bullish
Danaher (NYSE:DHR) has successfully acquired Masimo, integrating its patient monitoring and sensor technologies into Danaher's diagnostics portfolio. ...
Danaher has completed its $9.5 billion cash acquisition of Masimo, integrating it into Danaher’s Diagnostics segment as a standalone subsidiary and de...
Neutral
Nuveen LLC trimmed its holdings in shares of Danaher Corporation (NYSE:DHR – Free Report) by 0.3% in the 4th quarter, according to the company in its ...
Neutral
UniSuper Management Pty Ltd reduced its stake in Danaher Corporation (NYSE:DHR) by 5.6% during the fourth quarter, selling 9,619 shares. Despite this,...
Neutral
Danaher has completed its $9.9 billion acquisition of Masimo, positioning itself as a major competitor to Medtronic in the pulse oximetry market. The ...